This’ll be quick. My talquetamab and Pomalyst doses have been reduced due to the effects on my pancreas. I started a few weeks ago on 4 mg of Pom. Now I’m taking 3 mg. Talquetamab was administered at 400 micrograms/kg, and now I’ll be getting 135. I was feeling as though I’d had a punch in the gut, and my lipase results were elevated. A CT scan didn’t reveal any pancreas disease, but the study team decided it’s better not to allow it to get that far.
One of the RNs told me that MANY people have trouble tolerating Pomalyst.
I had Zometa today, too.
I’ll post some test results next time.